All data are based on the daily closing price as of April 1, 2025
b

BML

4694.TSE
20.35 USD
0.09
+0.44%

Overview

Last close
20.35 usd
Market cap
793.44M usd
52 week high
20.63 usd
52 week low
16.88 usd
Target price
20.05 usd

Valuation

P/E
18.6014
Forward P/E
N/A
Price/Sales
0.8488
Price/Book Value
0.9228
Enterprise Value
327.19M usd
EV/Revenue
0.3464
EV/EBITDA
4.9879

Key financials

Revenue TTM
930.61M usd
Gross Profit TTM
581.18M usd
EBITDA TTM
107.57M usd
Earnings per Share
1.05 usd
Dividend
0.27 usd
Total assets
1.11B usd
Net debt
-424.97M usd

About

BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures. It also provides medical information system services, which include electronic medical charts for networking medical information, as well as preventive medicine services. In addition, the company offers food sanitation test, including food sanitation control and food processing services, which comprise contract services for microorganism testing of raw materials, and prepared and processed food; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and wastewater tests; work environment services, such as measurement of ethylene oxide gas, formaldehyde, organic solvent, and dust; environmental monitoring, which include measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; human genome analysis services; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.
  • Symbol
    4694.TSE
  • Exchange
    TSE
  • Isin
    JP3799700004
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Diagnostics & Research
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.bml.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top